Literature DB >> 17222580

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

Matthew J Farrer1, Jeremy T Stone, Chin-Hsien Lin, Justus C Dächsel, Mary M Hulihan, Kristoffer Haugarvoll, Owen A Ross, Ruey-Meei Wu.   

Abstract

The goal of genetic association studies is to identify common (>5%) risk factors in complex disease traits. Herein we describe the first replicable 'functional' risk allele for Parkinson's disease. The leucine-rich repeat kinase 2 (Lrrk2) G2385R substitution is associated with familial parkinsonism, late-, and early-onset Parkinson's disease in ethnic Chinese Taiwanese. Crucially, we provide evidence of identity-by-descent and suggest that Lrrk2 G2385R carriers originate from one ancestor some 4800 years ago, at the start of Chinese civilization. Moreover, our findings demonstrate that common genetic coding variants contribute to Parkinson's disease in a population specific manner which may have important implications for future genome-wide association studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222580     DOI: 10.1016/j.parkreldis.2006.12.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  64 in total

1.  Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

Authors:  M Yue; K M Hinkle; P Davies; E Trushina; F C Fiesel; T A Christenson; A S Schroeder; L Zhang; E Bowles; B Behrouz; S J Lincoln; J E Beevers; A J Milnerwood; A Kurti; P J McLean; J D Fryer; W Springer; D W Dickson; M J Farrer; H L Melrose
Journal:  Neurobiol Dis       Date:  2015-03-31       Impact factor: 5.996

2.  Phactr2 and Parkinson's disease.

Authors:  Christian Wider; Sarah J Lincoln; Michael G Heckman; Nancy N Diehl; Jeremy T Stone; Kristoffer Haugarvoll; Jan O Aasly; J Mark Gibson; Timothy Lynch; Alex Rajput; Michele L Rajput; Ryan J Uitti; Zbigniew K Wszolek; Matthew J Farrer; Owen A Ross
Journal:  Neurosci Lett       Date:  2009-02-10       Impact factor: 3.046

3.  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Authors:  Owen A Ross; Alexandra I Soto-Ortolaza; Michael G Heckman; Jan O Aasly; Nadine Abahuni; Grazia Annesi; Justin A Bacon; Soraya Bardien; Maria Bozi; Alexis Brice; Laura Brighina; Christine Van Broeckhoven; Jonathan Carr; Marie-Christine Chartier-Harlin; Efthimios Dardiotis; Dennis W Dickson; Nancy N Diehl; Alexis Elbaz; Carlo Ferrarese; Alessandro Ferraris; Brian Fiske; J Mark Gibson; Rachel Gibson; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Beom S Jeon; Yun Joong Kim; Christine Klein; Rejko Kruger; Elli Kyratzi; Suzanne Lesage; Chin-Hsien Lin; Timothy Lynch; Demetrius M Maraganore; George D Mellick; Eugénie Mutez; Christer Nilsson; Grzegorz Opala; Sung Sup Park; Andreas Puschmann; Aldo Quattrone; Manu Sharma; Peter A Silburn; Young Ho Sohn; Leonidas Stefanis; Vera Tadic; Jessie Theuns; Hiroyuki Tomiyama; Ryan J Uitti; Enza Maria Valente; Simone van de Loo; Demetrios K Vassilatis; Carles Vilariño-Güell; Linda R White; Karin Wirdefeldt; Zbigniew K Wszolek; Ruey-Meei Wu; Matthew J Farrer
Journal:  Lancet Neurol       Date:  2011-08-30       Impact factor: 44.182

4.  Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.

Authors:  Da-Wei Li; Zhuqin Gu; Chaodong Wang; Jinghong Ma; Bei-Sha Tang; Sheng-Di Chen; Piu Chan
Journal:  J Neural Transm (Vienna)       Date:  2014-07-26       Impact factor: 3.575

5.  LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.

Authors:  Chao Gao; Hao Pang; Xiao-Guang Luo; Yan Ren; Hong Shang; Zhi-Yi He
Journal:  J Neurol       Date:  2013-08-30       Impact factor: 4.849

6.  Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Authors:  Ming Cao; Zhu-Qin Gu; Yuan Li; Hui Zhang; Xiao-Juan Dan; Shan-Shan Cen; Da-Wei Li; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

7.  LRRK2 variation and dementia with Lewy bodies.

Authors:  Michael G Heckman; Alexandra I Soto-Ortolaza; Monica Y Sanchez Contreras; Melissa E Murray; Otto Pedraza; Nancy N Diehl; Ronald Walton; Catherine Labbé; Oswaldo Lorenzo-Betancor; Ryan J Uitti; Jay van Gerpen; Nilüfer Ertekin-Taner; Glenn E Smith; Kejal Kantarci; Rodolfo Savica; David T Jones; Jonathan Graff-Radford; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Joseph E Parisi; Rosa Rademakers; Zbigniew K Wszolek; Neill R Graff-Radford; Tanis J Ferman; Dennis W Dickson; Bradley F Boeve; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2016-07-29       Impact factor: 4.891

8.  LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.

Authors:  E K Tan; Louis C Tan; H Q Lim; R Li; M Tang; Yuen Yih; R Pavanni; K M Prakash; S Fook-Chong; Yi Zhao
Journal:  Hum Genet       Date:  2008-09-10       Impact factor: 4.132

Review 9.  Genes associated with Parkinson syndrome.

Authors:  Saskia Biskup; Manfred Gerlach; Andreas Kupsch; Heinz Reichmann; Peter Riederer; Peter Vieregge; Ullrich Wüllner; Thomas Gasser
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

10.  The WD40 domain is required for LRRK2 neurotoxicity.

Authors:  Nathan D Jorgensen; Yong Peng; Cherry C-Y Ho; Hardy J Rideout; Donald Petrey; Peng Liu; William T Dauer
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.